Tucatinib - CaLiGraph

CaLiGraph

Property	Value
rdf:type	Antineoplastic drug Receptor tyrosine kinase inhibitor owl:NamedIndividual Cancer treatment Orphan drug Quinazoline Drug granted breakthrough therapy designation Triazolopyridine
rdfs:label	Tucatinib
owl:sameAs	dbr:Tucatinib
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:Cancer_treatments http://en.wikipedia.org/wiki/Category:Orphan_drugs http://en.wikipedia.org/wiki/Category:Quinazolines http://en.wikipedia.org/wiki/Category:Triazolopyridines http://en.wikipedia.org/wiki/Category:Antineoplastic_drugs http://en.wikipedia.org/wiki/Protein_kinase_inhibitor http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/Category:Receptor_tyrosine_kinase_inhibitors
skos:prefLabel	Tucatinib
skos:altLabel	tucatinib
clgo:alternativeName	Tukysa
clgo:casNumber	937263-43-9
clgo:chEMBL	3989868
clgo:drugbank	DB11652
clgo:fdaUniiCode	234248D0HH
clgo:kegg	D11141
clgo:medlinePlus	a620032
clgo:pubchem	51039094

About: clgr:Tucatinib